ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Critical Care Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,650Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 38

$1.88M Total Retail Price of All Prescriptions

Rank: 2 out of 38

691 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

28% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 25,815 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 53%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $134 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 1,160 1,008 1 3
SIMVASTATIN 1,022 857 2 4
HYDROCODONE-ACETAMINOPHEN 1,008 730 S3 3 7
FUROSEMIDE 880 790 4 5
METOPROLOL TARTRATE 789 695 5 13
LISINOPRIL 785 716 6 8
DONEPEZIL HCL 776 737 7 15
AMLODIPINE BESYLATE 702 626 8 9
LANTUS 594 510 9 23
MIRTAZAPINE 591 549 10 27
OMEPRAZOLE 554 484 11 11
NAMENDA 542 516 12 16
WARFARIN SODIUM 534 476 13 20
TRAMADOL HCL 472 414 14 17
SERTRALINE HCL 451 383 15 25
QUETIAPINE FUMARATE 448 382 16 32
POTASSIUM CHLORIDE 439 404 17 19
METFORMIN HCL 382 311 18 14
CITALOPRAM HBR 331 281 19 31
GABAPENTIN 327 250 20 24
TRAZODONE HCL 321 258 21 29
CYMBALTA 316 260 22 30
DIVALPROEX SODIUM 310 251 23 56
CARVEDILOL 268 248 24 21
LATANOPROST 259 242 25 63
ZOLPIDEM TARTRATE 251 214 26 33
ABILIFY 240 197 27 79
RISPERIDONE 238 183 28 48
NOVOLIN R 237 206 29 55
ALENDRONATE SODIUM 234 224 30 50
LEVETIRACETAM 233 147 31 68
CLOPIDOGREL 224 207 32 38
METOPROLOL SUCCINATE 213 184 33 35
CARBIDOPA-LEVODOPA 211 211 34 67
BACLOFEN 203 118 35 46
HYDROCHLOROTHIAZIDE 197 179 36 49
LACTULOSE 196 150 37 37
FLUTICASONE PROPIONATE 190 147 38 22
CLONIDINE HCL 172 150 39 47
NOVOLOG 172 142 39 99
ESCITALOPRAM OXALATE 171 139 41 80
RAMIPRIL 170 142 42 65
DIOVAN 169 156 43 69
POLYETHYLENE GLYCOL 3350 169 128 43 64
MELOXICAM 166 155 45 60
BENZTROPINE MESYLATE 166 122 R 45 76
PROMETHAZINE HCL 164 131 R 47 102
RANITIDINE HCL 159 137 48 51
SPIRIVA 158 146 49 1
ATORVASTATIN CALCIUM 158 124 49 40
LIDODERM 155 136 51 105
KLOR-CON M20 155 139 51 83
DIGOXIN 155 154 51 71
TAMSULOSIN HCL 153 104 54 38
PLAVIX 146 131 55 53
ISOSORBIDE MONONITRATE ER 141 118 56 61
SEROQUEL 139 127 57 84
FAMOTIDINE 138 108 58 52
AMIODARONE HCL 136 113 59 81
ADVAIR DISKUS 135 132 60 2
ROPINIROLE HCL 134 114 61 91
ATENOLOL 133 99 62 57
HUMALOG 133 109 62 115
LOSARTAN POTASSIUM 132 122 64 77
IPRATROPIUM-ALBUTEROL 122 112 65 122
AGGRENOX 118 74 66 123
ALBUTEROL SULFATE 115 106 67 45
EXELON 111 97 68 72
PRAVASTATIN SODIUM 111 92 68 44
HYDRALAZINE HCL 110 88 70 34
LYRICA 110 110 70 74
IBUPROFEN 109 88 72 103
GLIPIZIDE 107 107 73 75
PHENYTOIN SODIUM EXTENDED 106 67 74 87
PATANOL 105 85 75 128
SPIRONOLACTONE 104 90 76 97
ENALAPRIL MALEATE 104 82 76 129
OXYBUTYNIN CHLORIDE ER 104 90 76 129
PAROXETINE HCL 103 90 79 90
JANUVIA 103 99 79 131
DETROL LA 103 102 79 131
CLONIDINE 103 78 79 92
SINGULAIR 102 92 83 18
NYSTATIN 100 89 84 104
PREDNISONE 98 77 85 6
BRIMONIDINE TARTRATE 96 92 86 135
ALLOPURINOL 91 91 87 59
VENLAFAXINE HCL ER 91 81 87 109
VALPROIC ACID 89 55 89 86
KLOR-CON M10 85 73 90 142
FLUOXETINE HCL 82 58 91 96
GLYBURIDE 81 64 R 92 107
OXYBUTYNIN CHLORIDE 79 53 93 97
LEVOFLOXACIN 77 68 94 58
METOCLOPRAMIDE HCL 75 58 95 149
VENLAFAXINE HCL 75 64 95 149
BUSPIRONE HCL 74 64 97 73
PANTOPRAZOLE SODIUM 72 66 98 43
PHENYTOIN 71 24 99 99
NYSTOP 71 70 99 152
NIFEDIPINE ER 70 67 101 117
GLUCAGEN 69 56 102 154
NEXIUM 68 51 103 26
JANTOVEN 68 67 103 155
CYCLOBENZAPRINE HCL 68 35 R 103 78
TOPIRAMATE 68 18 103 92
HUMULIN R 66 53 107 116
TIMOLOL MALEATE 65 61 108 157
OLANZAPINE 65 44 108 157
TRAVATAN Z 65 63 108 157
HYDROXYZINE HCL 64 57 R 111 112
CRESTOR 64 44 111 111
HALOPERIDOL 64 58 111 161
LEXAPRO 64 57 111 161
DORZOLAMIDE-TIMOLOL 63 63 115 164
FINASTERIDE 62 62 116 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 53 117 101
DILTIAZEM 24HR CD 58 58 117 126
AMITRIPTYLINE HCL 58 44 R 117 174
LEVEMIR 57 53 120 177
FENTANYL 55 40 S2 121 185
GLIMEPIRIDE 55 55 121 70
VESICARE 53 24 123 188
MONTELUKAST SODIUM 52 47 124 36
BYSTOLIC 51 39 125 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.